![Dawn P. Eringis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dawn P. Eringis
Corporate Officer/Principal bei PolyMedix Pharmaceuticals, Inc.
Aktive Positionen von Dawn P. Eringis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PolyMedix Pharmaceuticals, Inc. | Corporate Officer/Principal | 01.01.2003 | - |
Karriereverlauf von Dawn P. Eringis
Ehemalige bekannte Positionen von Dawn P. Eringis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Locus Pharmaceuticals, Inc.
![]() Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Corporate Officer/Principal | 01.01.2000 | 01.01.2002 |
POLYMEDIX, INC. | Corporate Officer/Principal | 01.11.2005 | - |
Ausbildung von Dawn P. Eringis
University of Pennsylvania | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Corporate Officer/Principal | 3 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
PolyMedix, Inc.
![]() PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology PolyMedix, Inc. engaged in developing first-in-class, small-molecule defensin-mimetics for the treatment of serious acute care conditions. The company was founded in 2002 and was headquartered in Radnor, PA. | Health Technology |
PolyMedix Pharmaceuticals, Inc. | |
Locus Pharmaceuticals, Inc.
![]() Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Health Technology |
- Börse
- Insiders
- Dawn P. Eringis
- Erfahrung